Zhiqiang Chen Selected Research

Zhiqiang Chen Research Topics

Disease

50	Neoplasms (Cancer) 05/2022 - 11/2008
13	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 11/2008
13	Inflammation (Inflammations) 06/2021 - 11/2016
10	Carcinogenesis 01/2021 - 01/2016
9	Kidney Calculi (Kidney Stone) 02/2022 - 01/2014
9	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2014
7	Glioma (Gliomas) 10/2022 - 07/2010
7	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2016
7	Renal Cell Carcinoma (Grawitz Tumor) 09/2021 - 03/2018
7	Hypoxia (Hypoxemia) 01/2021 - 01/2011
7	Stomach Neoplasms (Stomach Cancer) 12/2020 - 02/2014
6	Nephrocalcinosis 01/2022 - 12/2019
5	Infections 01/2022 - 01/2010
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 12/2017
5	Wounds and Injuries (Trauma) 05/2018 - 10/2003
5	Renal Colic 03/2018 - 07/2011
5	Hearing Loss (Hearing Impairment) 05/2010 - 10/2003
5	Noise-Induced Hearing Loss (Acoustic Trauma) 05/2010 - 01/2003
4	COVID-19 08/2022 - 09/2020
4	Fibrosis (Cirrhosis) 01/2021 - 01/2017
4	Asthma (Bronchial Asthma) 01/2020 - 11/2017
3	Colonic Neoplasms (Colon Cancer) 05/2022 - 11/2018
3	Hydronephrosis 09/2021 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 08/2021 - 09/2018
3	Nephrolithiasis 06/2021 - 01/2014
3	Pain (Aches) 01/2021 - 01/2005
3	Hemorrhage 01/2021 - 08/2011
3	Pathologic Processes 01/2020 - 09/2018
3	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 01/2005
3	Hyperoxaluria (Oxaluria) 05/2019 - 04/2012
3	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2008
2	Ovarian Neoplasms (Ovarian Cancer) 10/2022 - 07/2017
2	Lymphatic Metastasis 12/2021 - 01/2021
2	Pyonephrosis 03/2021 - 01/2020
2	Cholangiocarcinoma 01/2021 - 01/2021
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2017
2	Shock 01/2021 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 01/2020
2	Adenocarcinoma of Lung 07/2020 - 02/2014
2	Urinary Calculi (Urinary Calculus) 01/2020 - 11/2016

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2004
12	Calcium OxalateIBA 01/2022 - 04/2012
11	Biomarkers (Surrogate Marker)IBA 09/2021 - 10/2017
10	Circular RNAIBA 03/2022 - 01/2018
10	Biological ProductsIBA 12/2021 - 12/2011
7	Messenger RNA (mRNA)IBA 05/2022 - 02/2004
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2014
6	CateninsIBA 01/2022 - 01/2017
6	Tamsulosin (Flomax)FDA LinkGeneric 01/2021 - 07/2011
5	Therapeutic UsesIBA 01/2022 - 10/2003
5	glyoxylic acid (glyoxylate)IBA 01/2021 - 01/2019
5	CytokinesIBA 01/2020 - 01/2011
4	VaccinesIBA 01/2022 - 01/2021
4	HMGB1 Protein (HMG1)IBA 12/2019 - 12/2012
4	caroverine (P-201)IBA 12/2006 - 01/2003
3	AntigensIBA 08/2022 - 10/2018
3	IronIBA 01/2022 - 05/2012
3	Chelating AgentsIBA 01/2022 - 05/2012
3	RNA (Ribonucleic Acid)IBA 12/2021 - 02/2004
3	Pharmaceutical PreparationsIBA 09/2021 - 09/2014
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 11/2017
3	AcidsIBA 05/2019 - 07/2004
3	OxalatesIBA 03/2018 - 04/2012
3	EnzymesIBA 03/2018 - 12/2011
3	Glutamic Acid (Glutamate)FDA Link 05/2010 - 11/2004
3	N-Methylaspartate (NMDA)IBA 11/2004 - 01/2003
3	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2004 - 01/2003
2	sulforaphaneIBA 01/2022 - 01/2020
2	EpitopesIBA 01/2022 - 01/2021
2	Competitive Endogenous RNAIBA 12/2021 - 12/2019
2	Hemoglobins (Hemoglobin)IBA 09/2021 - 11/2016
2	AlbuminsIBA 09/2021 - 01/2021
2	GlobulinsIBA 09/2021 - 01/2021
2	Small Interfering RNA (siRNA)IBA 08/2021 - 09/2018
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2011
2	tongluoIBA 01/2021 - 01/2017
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 04/2020
2	Long Noncoding RNAIBA 01/2021 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 09/2019
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 05/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2017
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 09/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2006
2	AndrogensIBA 01/2021 - 09/2019
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 12/2020 - 01/2020
2	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2020 - 01/2020

Therapy/Procedure

24	Therapeutics 03/2022 - 01/2011
7	Percutaneous Nephrolithotomy 02/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 12/2021 - 01/2006
4	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 05/2017
3	Length of Stay 02/2022 - 04/2017
3	Radiotherapy 12/2021 - 02/2014
3	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2021 - 08/2011
2	Immunotherapy 03/2022 - 01/2021
2	Punctures 09/2021 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 10/2015
2	Blood Transfusion (Blood Transfusions) 03/2021 - 11/2016
2	Castration 01/2021 - 01/2021
2	Aftercare (After-Treatment) 01/2021 - 01/2018